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ABSTRACT 
 
 
 
 
 
 
Schizophrenia (SCZ) is a heterogeneous syndrome with a chronic course that 
leads to relevant psychosocial impairment. The clinical phenomenology is 
typically defined by “positive” symptoms such as hallucinations and delusions 
and “negative” symptoms such as avolition and anhedonia, that are often 
associated with a progressive cognitive decline. Despite intensive research on 
the etiopathogenetic mechanisms of this disorder, clearly defined biological 
markers are still lacking. On the neurophysiological level, a marked reduction of 
sleep spindle activity has recently been described in patients with chronic, 
medicated SCZ and with early-course psychotic disorders. Whether such deficit 
can be considered a reliable marker of or an endophenotype of the disorder 
remains to be cleared. 
 
The objective of my work was to accurately study the electrophysiological 
features of sleep spindle activity in First-Degree Relatives (FDRs) of SCZ 
patients and in drug-naïve subjects with First-Episode Psychosis (FEP). A high-
density electroencephalogram (hd-EEG) with 256 channels was used to study a 
whole night of sleep in experimental subjects and in a sample of age- and 
gender-matched healthy control subjects. Several neurocognitive tests and 
clinical scales were also administered to FDR and FEP subjects in order define 
psychopathological status and vulnerability. None of the recruited subjects had 
received treatment with psychotropic medication. 
 
Among several analysed parameters of sleep macrosructure and 
microarchitecture, hd-EEG measurements revealed a significant reduction of 
Integrated Spindle Activity (ISAs) in FDR subjects. ISA was obtained by 
integrating the absolute amplitude values of each spindle detected at every 
electrode, divided by its duration. No relevant differences were observed in 
terms of spindle density and duration.  
 
Preliminary results from a small subgroup of drug-naïve FEP patients are also 
reported. The main findings of my work appear to support the view that sleep 
spindle deficit is an electrophyisological endophenotype of SCZ. Given the vast 
available knowledge on the cellular mechanisms underlying spindle activity, 
future perspectives include a molecular characterization in individuals who carry 
a known genetic vulnerability for thalamic dysfunction. 
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OUTLINE and MY CONTRIBUTION 
 
 
 
 
 
 
 
PART I: this section provides a general introduction to the current diagnosis of 
Schizophrenia. After a brief historical note, the recent framing of nosographical 
criteria and fundamental clinical features of the disorder are presented. 
 
PART II: in this chapter I briefly review the major empirical approaches that 
have been used to study the electrophysiology of Schizophrenia in wakefulness 
and during sleep. These include several recent studies conducted at our 
associate laboratory in the United States that began to characterize sleep 
spindle deficits in chronic, medicated patients. Many of the reported studies 
have been summarized in the recent publication: “Schizophrenia: from 
neurophysiological abnormalities to clinical symptoms.” 
 
PART III: in this chapter I report the major production of my Ph.D. work, focused 
on the characterization of sleep spindle abnormalities in a population of First-
Degree Relatives of patients diagnosed with Schizophrenia. This empirical 
approach is necessary to define the role of spindle deficits in the context of 
ongoing research. My findings seem to confirm the hypothesis that sleep 
spindles are an endophenotype rather than a clinical biomarker of the disorder. 
No definitive conclusions can be drawn from the second part of the chapter, in 
which very preliminary data are presented from a small group of drug-naïve, 
First Episode Psychosis patients. 
 
PART IV: in this section I draw initial conclusions, describe ongoing studies and 
the possibility of deepening the level of investigation over the 
neurophysiological mechanisms described in the previous chapters with an 
ongoing in vitro study on reprogrammed neuronal cells of Schizophrenia 
patients and First-Degree Relatives at our associate laboratory in the University 
of Trento. 
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1. DEMENTIA PRAECOX, OR THE GROUP OF SCHIZOPHRENIAS 
 
1.1. Historical context 
 
Schizophrenia (SCZ) is a heterogeneous disorder defined by a complex 
interaction of cognitive, behavioural and emotional dysfunctions. Despite 
intensive research in several fields, ranging from the genetic and biomolecular 
underpinnings of abnormal neural circuitry to neuropsychological and 
neurophysiological impairments, the core dysfunction remains elusive. The 
clinical phenomenology of this syndrome, originally termed Dementia Praecox 
(DP), was accurately studied at the turn of the 20th Century by Emil Kraepelin 
and Eugen Bleuler. These two authors clearly described signs and symptoms 
and defined the course and prognosis of the disorder (Bleuler, 1911; Kraepelin, 
1913). The detailed analysis of psychopathology, clinical presentation, course 
and outcome yields a prototypical model characterized by an insidious onset 
and progression, with episodic exacerbations and a residual outcome in which 
affective blunting predominates. SCZ is commonly viewed as a 
neurodevelopmental disturbance coupled with a neurodegenerative process 
that begins during early adulthood. On the clinical level, it can be viewed as a 
syndrome with recurring episodes in which precocious cognitive decline holds a 
central role. Acute episodes of the disorder are typically described as re-
exacerbations of psychotic symptoms such as hallucinations, delusions or 
disorganization. 
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Bleuler's reconceptualization of DP was based on two fundamental clinical 
observations. In terms of evolution and outcome, not all DP patients appeared 
to evolve towards dementia and not all clinical conditions of DP had an early 
onset. In terms of core pathophysiology, the disintegration of subjectivity 
(defined as a unity of all Ego functions) was apparently shared by all patients. 
Supported by the experimental work conducted by Carl Gustav Jung at 
Burghölzli, Bleuler attempted to explain the disintegration of subjectivity through 
the clarification of psychological dynamics. Among others, his view that 
psychotic symptoms should be interpreted along a continuum with non-
pathological phenomena and that neurophysiological and phenomenological 
features are shared with the experience of dreaming are still considered valid 
(Verdoux et al., 2002; D’Agostino and Scarone, 2013). 
 
Bleuler was the first to explore pathogenetic mechanisms of the disorder, with 
the consequence of also proposing psychologically-oriented therapeutical 
perspectives. This led some authors to erroneously interpret his conception of 
the disorder as opposed to that of Kraepelin (Moskowitz and Heim, 2011; 
Fusar-Poli et al., 2008). Bleuler considered DP and SCZ synonyms that defined 
“a group of psychoses which develops at times in a chronic mode, at times by 
surges, which can stop or retrocede at any stage, but which probably doesn't 
allow a complete restitutio ad integrum” (Bleuler, 1911). Therefore, DP and SCZ 
identify the same disorder with an irreversible and non-periodic course. As far 
as aetiology is concerned, both Krapelin and Bleuler were convinced of the 
biological origin of the disorder, with the former oriented towards an exogenous, 
possibly toxi-infective insult, the latter more convinced of an endogenous, 
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primitive pathological modification of the brain. Our current understanding of the 
disorder confirms both authors had precociously hypothesized crucial 
mechanisms, with confirmed risk factors for SCZ ranging from genetic 
susceptibility to environmental insults (Meyer-Lindenberg, 2010). 
 
1.2. Schizophrenia Spectrum in the DSM-5 
 
From its third edition onwards, the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) centred its clinical definition of SCZ on the transversal 
observation of psychotic signs and symptoms. This approach owes much to the 
conceptualization of the schizophrenic disorder operated by Kurt Schneider 
(Schneider, 1959), as explicitly recognized by some members of the American 
Psychiatric Association (APA) task force (Spitzer et al., 1978) In the latest 
edition of the DSM, Schizophrenia was conceptualized within a spectrum of 
diagnoses which includes Schizotypal Personality Disorder, Delusional 
Disorder, Brief Psychotic Disorder, Schizophreniform Disorder, Schizoaffective 
Disorder, Substance/Medication-Induced Psychotic Disorder, Psychotic 
Disorder Due to Another Medical Condition, Catatonic Disorders and other 
specified/unspecified Schizophrenia Spectrum Disorders (APA, 2013). DSM-5 
diagnostica criteria for SCZ can be visualized in Figure 1.1
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Figure 1.1 Schizophrenia in DSM-5. Right column: Diagnostic criteria. Whereas no significant change was made in 
DSM-5 to criteria B and E, several changes were made to A and F. First of all, Schneiderian First-Rank Symptoms and 
bizarre delusions, previously considered pathognomic, have now been removed. Indeed, a growing amount of evidence 
appear to suggest these symptoms lack specificity, occurring as they do in other affective and non-affecitve psychotic 
disorders (Tandon, 2013). The presence of at least one positive symptom has also been introduced by DSM-5. 
Regarding Criterion F, in the previous version of the manual a diagnosis of SCZ could be made whenever hallucinations 
and delusions occurred in the presence of a previous history of autistic or pervasive developmental disorder. Given that 
other communication disorders exist with negative symptoms and disorganization at the onset (Dyck et al., 2011), the 1-
month timeframe should allow a major diagnostic accuracy between SCZ and pervasive developmental disorders. 
Finally, the major change was the loss of the four SCZ subtypes (disorganized, catatonic, paranoid, undifferentiated). 
This choice was sustained by two evidences: First of all, the distinction is nota t alla clear as the disorder progresses 
and, second, there doesn’t appear to be a specific treatment choice for any of the subtypes. Only 5% of analysed 
studies found significant differences based on subtypes of the disorder, suggesting a lack of clinical and prognostic 
validity of such categorization (Braff et al., 2013). Left column: Course and severity specifiers. DSM-5 includes  
specifiers to identify the observed status (absent, partial or full remission from the acute phase) and the course of 
illness. These specifiers appear to be more valuable in directing a therapeutic approach based on the stage of the 
disorder and to be more accurate in prognostic terms at the level of single patients (Galderisi et al., 2013). 
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1.3. Clinical and epidemiological aspects of Schizophrenia 
 
1.3.1 Epidemiology 
 
SCZ is a relatively frequent disorder with an estimated world prevalence ranging 
from 0,3-0,66 to 1% and an incidence of 10,2-22 new cases per 100.000 
persons/year (McGrath et al., 2008). However, data are often considered to be 
underestimated due to the unclear nosographical boundaries of the SCZ 
concept. Epidemiological data are mostly drawn from hospital registries so 
patients who never make contact with psychiatric services are difficult to 
estimate. 
 
SCZ typically develops during late adolescence or young adulthood, peaking 
between 15 to 30 years of age. Incidence is higher in men, who also tend to 
have an earlier onset compared to women. Although rare, Early-Onset 
Schizophrenia (EOS) and Very-Early Onset Schizophrenia (VEOS) cases are 
reported in childhood, with a clear predominance of the male gender (McClellan 
e Stock, 2013). Typical aspects of the disorder overlap with the adult syndrome, 
but diagnosis is highly complex in children given that positive symptoms can be 
less elaborate and that visual hallucinations – easily confused with commonly 
reported fantasy play - tend to prevail. Furthermore, disorganization can be 
observed in many childhood onset neuropsychiatric syndromes and bizarre 
behaviour also occurs in children with Attention Deficit and Hyperactivity 
Disorder (ADHD). At the other end of the spectrum, the terms Late-Onset and 
Very Late-Onset Schizophrenia have been used for cases diagnosed after the 
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ages of 40 and 60. The majority of cases are women, with a predominance of 
psychotic symptoms with preserved affectivity and global functioning. Although 
criteria for the disorder are fullfilled, it remains unclear whether the pathogenetic 
mechanisms can be considered similar to those that are currently hypothesized 
to underlie conventional SCZ cases. 
 
1.3.2 Course and outcome 
 
The course of SCZ is highly variable, both inter- and intraindividually; symptom 
presentation and intensity, temporal evolution and remission rates vary 
considerably and are influenced by psychopharmacological interventions. 
Some meta-analytic studies on the longitudinal course of the disorder found that 
up to 30% of patients treated at the First Episode had no re-exacerbations in 
the subsequent 5 years, whereas the majority of follow-up studies up to 40 
years suggest that 20-70% of subjects have a chronic illness with re-
exacerbations (Hegarty et al., 1994). 
 
5-6% of subjects diagnosed with SCZ die by suicide, whereas up to 20% have a 
personal history of one or more suicide attempts. These can be secondary to 
hallucinatory commands including imperative voices that lead the subject to 
self-harm. Suicidal risk tends to remain high in both male and female subjects 
and is usually increased in those with Substance Use Disorder co-morbidity. 
Further risk factors for self-harm in SCZ are symptoms of depression / despair 
and the lack of a job; risk has been shown to increase during the period 
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immediately after a hospitalization caused by a psychotic re-exacerbation 
(Hegarty et al., 1994). 
 
1.3.3 From the prodrome to Schizophrenia 
 
The onset of SCZ is commonly preceded by a prodromal phase that can be 
characterized by mood, cognitive and attenuated psychotic symptoms. These 
are usually subthreshold in clinical terms and highly unspecific, so a clear 
distinction with temperamental traits or unusual subjective experiences of a 
healthy individual is highly complex. 
 
The concept of a prodromal state, variously termed as High Risk (HR), Ultra-
High Risk (UHR) or At-Risk Mental State (ARMS) was introduced to aid 
research and interventional programs in the early identification of SCZ. Several 
objective criteria have been proposed over time, although clear consensus 
remains to be reached. The “Basic Symptoms” (BS) concept is used to define 
disturbing subjective experiences that can be observed before and after a first 
psychotic episode (Gross, 1989). The Brief Psychiatric Rating Scale (BPRS, 
Overall and Gorham, 1962) and the Comprehensive Assessment of Symptoms 
and History (CASH, Andreasen, 1992) scales were used to measure the 
intensity of symptons, but a new scale was later developed to include an 
evaluation of duration and frequency, called Comprehensive Assessment of at 
Risk Mental State (CAARMS, Yung et al., 2005). BS appear to define an early 
prodromal stage and then wane, whereas CAARMS can detect later prodromal 
stages that are closer to the development of full blown psychotic symptoms.  
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High-Risk subjects do not appear as an homogeneous group and they can be 
divided in several subcategories as shown in Figure 1.2. Early identification of 
specific symptom domains in at-risk groups could lead to individualized 
treatment or follow-up programs to attempt a reduction in transition rates to SCZ 
(Fusar-Poli et al., 2013). 
 
 
Figure 1.2. Prodromal stages of Schizophrenia. During the prodromal stage, subjects can be subdivided according to 
the following criteria (i) Attenuated Psychotic Symptoms (APS) that must have occurred in the previous year with 
attenuated intensity (APSa) or frequency (APSb); (ii) Brief Limited Intermittent Psychotic symptoms (BLIP), i.e. 
symptoms that resolve spontaneously within a year of their onset; (iii) subjects with a SCZ trait carrying a hypothetic 
vulnerability to psychosis, i.e. an affected FDR and with low sociofunctional status for at least a month of the previous 
year (Fusar-Poli, 2013). 
 
1.4. Etiopathogenetic hypotheses of Schizophrenia 
 
There are currently no radiological, laboratory or psychometric tests employed 
for the diagnosis of SCZ. Nontheless, differences are evident from 
neuroimaging, neuropathological, and neurophysiological studies in multiple 
brain regions between groups of healthy individuals and SCZ patients. Clear 
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differences have also been reported in cellular architecture, white matter 
connectivity and gray matter volume in a variety of regions such as the 
prefrontal and temporal cortices. Reduced overall brain volume has been 
observed, as well as increased brain volume reduction with age. Neurological 
“soft” signs including impaired motor coordination, sensory integration, and 
motor sequencing of complex movements; left-right confusion; disinhibition of 
associated movements are also commonly reported, along with minor physical 
abnormalities of the face and limbs. SCZ is considered close to autism 
spectrum disorders and neurodevelopmental disorders (Rapoport, 2009), with 
which genetic abnormalities and etiopathogentic pathways appear to be shared. 
SCZ is framed as a neurodevelopmental disturbance with multifactioral etiology, 
occurring in genetically vulnerable subjects on which multiple environmental 
and epigenetic factors trigger the onset of the disorder. 
 
As far as genetic factors are concerned, approximately 80% of SCZ patients 
have a family history of the disorder, with a lifetime risk of developing the 
disorder in FDR of 6,5 % compared to 0,5% of the general population and 46% 
of subjects with both parents affected (van Os and Kapur, 2009). The major 
studies in this field included families of SCZ patients with mono- and dizygotic 
twins and adopted children, in order to discriminate between environmental and 
genetic impact. 
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1.4.1 Genetic models 
 
Despite the evidence of a strong genetic influence on the development of SCZ, 
most affected individuals have no family history of any Psychotic Disorder. 
Liability appears to be conferred by a spectrum of common and rare risk alleles, 
with each contributing only a small fraction to the total population variance. 
Identified risk alleles are also associated with other major mental disorders, 
including Mood Disorders and Autism Spectrum Disorders. Indeed, a polygenic, 
multifactorial model is often used to explain SCZ (Haller, 2014). Several genes, 
many of which unknown, are thought to contribute a small increase of risk in 
carriers. The co-existence of multiple vulnerability polymorphisms within the 
same subject increases the risk of developing the disorder and combination with 
environmental factors leads to surpassing a susceptibility threshold thereby 
causing the disorder. Specific genes that have been most closely correlated 
with SCZ are Neuregulin 1 (NRG1), Dysbindin 1 (DTNBP1) localized on 
chromosome 6; DISC 1 (DISrupted in SChizophrenia) on chromosome 1 which 
appears to be involved in neuronal migration and arborization; genes coding for 
Catechol-O-methyl transferase (COMT), catecholamine-degrading enzymes 
that are also disrupted in the 22q11 deletion that determines De George 
syndrome, a disorder in which psychotic symptoms occur in up to 25% of 
subjects. However, the largest Genome-Wide Association Study (GWAS) 
conducted to date, identified 108 distinct genetic loci based on 36,989 patients 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). 
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1.4.2 Environmental risk factors 
 
The major environmental risk factors are obstetric complications and perinatal 
factors. Pre-eclampsia, Diabetes, Rh incompatibility, bleeding, abnormal fetal 
growth and development have all been associated with significant increases of 
risk to develop SCZ. Asphyxia, uterine atony and emergency Cesarean section 
have also been found to occur more commonly in the history of affected 
individuals. Hippocampal volume has been shown to be reduced in SCZ 
patients with a history of obstetric complications. Several animal studies have 
confirmed a strong relationship between intrauterine or intrapartum hypoxic 
insults and a vast array of developmental CNS abnormalities such as NMDA 
receptor reductions, increased DA release, white matter abnormalities, 
abnormalities of sleep/wake activation pathways (Schmitt et al., 2007; Mittal et 
al., 2008). 
 
Increased paternal age and early exposure to various infectious agents also 
appear to confer a relevant risk increase for SCZ. Significant associations have 
been reported for Influenza viruses, Herpesvirus Simplex, Rubeovirus and 
Toxoplasma gondii. These agents have been hypothesized to interfere with 
neurodevelopmental trajectories directly by transplacental passage and 
indirectly by increasing proinflammatory cytokines produced during the maternal 
infection (Brown, 2011). 
 
Major risk factors during adult life are physical and psychological stresses. The 
incidence of SCZ and related disorders is higher for children growing up in an 
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urban environment and for some minority ethnic groups. Cannabis use has also 
clearly been shown to increase the risk for psychosis and lead to increased 
rates of SCZ (Brown, 2011). 
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PART II 
	  
THE ELECTROPHYSIOLOGY 
OF SCHIZOPHRENIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  21	  
2.	  RECORDING	  BRAIN	  OSCILLATIONS	  
 
The electric activity of the brain can be measured across different frequency 
bands. Lower ranges include delta (<4 Hz), theta (4-8 Hz) and alpha (8-12 Hz), 
followed by high ranges beta (12-30 Hz) and gamma (>30 Hz) and ultrafast 
frequency ranges (>80 Hz) that have recently begun to gain more attention with 
a refinement and increase in sensitivity of available techniques. Oscillatory 
activity can be recorded at different levels, ranging to single cell potentials to 
complex neuronal activity inferred by measuring scalp potentials. Oscillations in 
humans are typically recorded with scalp electroencephalography (EEG), 
whereas depth electrodes implanted in neurosurgical patients have only 
recently employed to record oscillatory currents from subcortical structures. 
Extracellular local field potentials measure the sum of oscillatory activity from 
large groups of neurons. These extracellular currents are generated from a 
spatial addition of post-synaptic potentials of active cells. Indeed, EEG records 
the bioelectrical cerebral activity from the scalp and is a graphical 
representation of a difference in electric potential between two electrodes. The 
more neurons activate synchronously and with a parallel orientation, the higher 
the amplitude of the recorded signal. 
 
Given the low conductivity of tissues, electrical currents attenuate with 
increased distance between the source and the recorder; furthermore, spatial 
diffusion and orientation of the recorder influence the reduction of voltage. The 
EEG signal is conducted by cables to amplifiers that are in turn connected to 
the acquisition and recording system.  
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3.	  EEG	  ABNORMALITIES	  IN	  SCHIZOPHRENIA	  
 
EEG recordings have been used extensively in SCZ research. Abnormalities 
such as an increase of power in low-frequency bands have been demonstrated 
throughout the course of illness, from the prodromal stage to chronic, medicated 
subjects. Several studies analysed the relationship between EEG parameters in 
various subtypes of SCZ, suggesting different topographical differences 
according to the specific subtype (Uhlaas and Singer, 2010). Despite such 
evidence the heterogeneity of the EEG picture has often been correlated to 
individual factors such as gender, age or ethnicity but also secondary and 
iatrogenic factors such as substance abuse or the long-term effect of 
psychopharmacological treatment. Technical aspects of recording such as open 
or closed eyes, the administration of cognitive tasks, the number and position of 
electrodes could also contribute to the variability across studies. 
 
A growing amount of data suggest that cognitive dysfunction in SCZ patients is 
associated with abnormal synchronization of oscillatory activity in low and high 
frequency bands (Garakh et al., 2015). Several functional neuroimaging studies 
suggest abnormal coordination among distributed cortical regions during resting 
conditions that first appeared to only occur during cognitive tasks. Recent 
theoretical and experimental studies also reported that the functional 
coordination of such distributed regions is mediated by the synchronization 
among local oscillatory activities that are active at different frequency bands. 
Many known cerebral functions are associated with electrical activity at specific 
frequencies. Recently, the study of event-related potentials focused on the 
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gamma band given its prominent role in cognitive functions such as sensory 
elaboration, attention and memory; a growing number of studies proved that 
task-induced, regional gamma oscillations are reduced in SCZ pateints (Kikuchi 
et al., 2011; Moran e Hong, 2011). However, other studies had previously 
correlated different frequency bands with abnormalities of cognitive processing. 
Abnormalities of neural oscillations have also been shown during the resting 
state in SCZ. In 2008, a meta-analysis revealed an increase of slow rhythms in 
SCZ patients and a reduction of high frequency activity (Boutros et al., 2008). 
The analysed studies employed sophisticated strategies to control for biases 
such as ocular movements – which increase slow waves – and used various 
different experimental set-ups. Therefore, overlapping findings across studies 
confirm their validity. The most significant difference in SCZ patients compared 
to healthy control subjects, patients diagnosed with mood disorder or 
schizotypal traits was found  in the theta and delta activity, which are increased 
in the frontotemporal regions of the brain (Garakh et al., 2015). The 
predominance of slow wave activity in frontal regions, with a reduction of blood 
flow and a consequent reduction of glucose is considered an 
electrophysiological correlate of hypofrontality in SCZ. Patients with an early 
onset of the disorder commonly have a higher power spectrum in slow rhythms 
and a reciprocal reduction of alpha rhythm; the increase of slow waves has also 
been found to be proportional to ventricle enlargement and negative symptoms. 
Subjects diagnosed with Schizoaffective Disorder share similar EEG patterns 
with SCZ patients, but the slow-wave increase more modest. Therefore, some 
authors suggested such feature should be considered a SCZ-specific EEG 
component compared to an “affective” alpha rhythm component (Schellenberg 
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et al., 1990). On the basis of such data, it seems plausible to conclude that an 
increase in delta (and – less convincingly – an increase of theta) could be a 
reliable marker of SCZ and that with adequate development this could become 
a valuable tool in the clinico-diagnostic domain. However, prolongation of 
recording times and standardization of artifact removal techniques to aid 
subsequent data analysis have been proposed to standardize methods and 
reduce heterogeneity of findings across studies (Boutros et al., 2008). 
 
4.	  ENDOPHENOTYPES	  IN	  SCHIZOPHRENIA	  RESEARCH	  
 
4.1. What are endophenotypes? 
 
The term endophenotype was introduced in the genetics of SCZ research as a 
measurable component, invisible to the eye, between genotype and clinical 
phenotype. Endophenotypes should be 1) associated with the clinical disorder 
but not part of its diagnostic criteria 2) heritable 3) independent of the state of 
illness, i.e. be present before the active pathology and/or after remissions 4) 
identifiable in unaffected relatives at a higher rate than the general population 
and it should 5) co-segregate with the disorder in families (Gottesman and 
Shields, 1973). The possibility of using an endophenotype as a prognostic 
marker is a further, highly desirable characteristic. The general idea that 
identification of the molecular bases is easier for endophenotypes than clinical 
phenotypes is broadly accepted, although genetic studies have been very few 
(Flint and Munafò 2007). Putative SCZ endophenotypes have been reported in 
several research domains, including but not limited to the fields of 
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neurophysiology (eyetracking dysfunction and abnormalities of 
electrophysiological indices such as PPI, P50, P300, N400), structural and 
functional neuroanatomy (cerebellar and olfactory tract abnormalities, reduced 
fronto-thalamo-cerebellar and fronto-striato-thalamic gray matter, cortical 
atrophy and abnormal development, enlargement of ventricles, hypofrontality),  
neuropsychology (reduced attention and vigiliance, working memory and 
executive deficits). 
 
4.2. Neuroimaging Endophenotypes of Schizophrenia 
 
HR subjects have been shown to have several abnormalties in terms of 
structure and volume of Gray Matter (Thermenos et al., 2013). The majority of 
available studies include structural or functional Magnetic Resonance Imaging, 
the latter usually associated with neuropsychological tasks across various 
different functions (attention, concentration, language, working memory); other 
studies employed DTI (Diffusion Tension Imaging) to analyze connections 
within white matter tracts. Despite several findings of regional volumetric 
reduction and disruptions of functional connectivity are commonly reported, data 
across different studies remain inconsistent. Major evidences regard the 
prefrontal cortex (PFC) as over half a dozen transversal studies found a 
volumetric reduction of such region whereas one longitudinal study found that 
HR subjects who went on to develop the illness had a global reduction of 
cerebral volume which was much more consistent in the PFC bilaterally when 
compared to those who had not illness. These patients also showed an 
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increase in the number of PFC gyri compared to those who did not develop the 
disorder (Harris et al., 2004). 
 
From a functional perspective, a left hyperactivity correlated with abnormalities 
on cognitive testing, suggesting a possible compensatory effect of structural 
deficits for HR subjects to obtain an adequate functional status. Parieto-
temporal structures also appear to be very engaged, with the Medial Temporal 
Lobe including the Hippocampus. Cortical thinning of these regions increases 
with time and correlates with severity of symptoms whereas fMRI studies 
showed increased activity of the left Medial Temporal Gyrus in those HR 
subjects who went on to develop the illness. Several studies found volume 
reductions of the amigdaloid-hippocampal complex and a functional reduction 
that was negatively correlated with verbal learning abilities (especially right 
parahippocampal) and cognitive function. Finally, some areas with less clear 
evidence of impairment were cerebellum and anterior cingulate cortex: the first 
was found to have a reduced volume, the second a reduced thickness 
especially in HR subjects with a higher genetic vulnerability and reduced 
function over several tasks (Thermenos et al., 2013). 
 
Two aspects must be considered in the evaluation of these data: first of all, 
most available studies lacked a comparison between SCZ and other psychotic 
disorders and particularly affective psychoses. Second, contrasting results often 
emerge across groups. This appears to depend on the heterogeneity of the HR 
population. A clear example are fidings showing hyperactivity of certain 
structures in HR and hypofunction in ultra-HR subgroups. Age-related 
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differences have also been observed, possibly due to the elelvated 
development of local connections among close areas in children, which are 
progressively substituted with connections among more distributed areas during 
growth. Furthermore, some abnormalities in HR adolescents have been found 
to normalize at 17 – 20 years of age, suggesting a fundamental role for mean 
age of recruited subjects (Gogtay et al., 2007; Figure 4.1). 
 
 
Figure 4.1. Cortical gray matter (GM) thickness of healthy siblings of patients with childhood-onset 
schizophrenia (COS) vs age–, gender– and scan interval–matched healthy controls. GM thickness in healthy 
siblings of patients with COS (n = 52; 113 scans) compared with healthy controls (n = 52; 108 scans) between ages 8 
through 28 years. Healthy siblings show significant GM deficits in the left prefrontal and bilateral temporal cortices and 
smaller deficits in the right prefrontal and inferior parietal cortices. These deficits in healthy siblings normalize with age, 
with no abnormalities remaining by age 20 years. Gray matter cortical thickness is adjusted for mean cortical thickness 
(Gogtay et al., 2007). 
 
4.3. Neurophysiological endophenotypes of Schizophrenia 
 
Several EEG measures have been proposed as putative endophenotypes of 
SCZ. Studies can be substantially divided in those analyzing resting-state, 
spontaneous EEG, Event-Related Potential (ERP) studies and sleep EEG 
studies. One study of resting-state, spontaneous EEG including 128 SCZ 
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patients, 80 healthy relatives and 110 control subjects, reported a significant 
increase in gamma frequency band for patients but not for the other two groups, 
whereas reduction of theta and alpha rhythm were observed in patients and 
relatives (Hong et al., 2012). 
 
ERP studies are based on continuous EEG recording during cognitive tasks. 
These studies indicate a modification of cerebral activity during a task. 
Responses are named with a letter (P for positive responses, N for negative 
ones) followed by the number of milliseconds elapsed from the stimulus to the 
event. The majority of ERP studies in SCZ can be divided into three categories. 
The first includes studies comparing patients with healthy control individuals; 
the second includes at-risk subjects in order to define the genetic susceptibity or 
endophenotype validity of a marker. The third category analyzes possible 
modifications of the marker during the course of antipsychotic treatment. One of 
the major ERP that has been identified as an endophenotype of SCZ is the 
P300. In a study designed to evaluate EEG during Clozapine treatment, P300 
responses were studied pre-/post-treatment in 47 patients. A comparison with 
the EEG of 66 healthy volunteers indicated that several generators of P300 
responses were modified after treatment and, furthermore, those of central and 
temporal regions had an 84% sensitivity in differentiating patients from control 
subjects (Ravan et al., 2012). 
 
Along with P300, abnormal response to an auditory stimulus named Mismatch 
Negativity (MMN) has often been studied as a putative endophenotype. MMN 
amplitude is reduced in SCZ and several recent studies further validated this 
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hypothesis by demonstrating that MMN is already impaired in the early stages 
of the disorder and in subjects whose symptoms are attenuated below the 
threshold for a clinical diagnosis (Hasey e Kiang, 2013). Another ERP 
component that has been studied as an endophenotype of SCZ is the Error-
Related Negativity (ERN), a negative ERP waveworm which peaks 
approximately 50 ms after a wrong response to a multiple response task. 
Although attenuated, this type of response can also be recorded when subjects 
are unaware of having made a mistake. ERN is reduced in SCZ patients as in 
ARMS and brothers of affected individuals. 
 
P50 is an example of a possible SCZ biomarker. It is an early ERP response to 
auditory stimuli. When two stimuli are presented in rapid sequence, the second 
evoked P50 is physiologically inferior to the first, with its percentual reduction 
termed p50 suppression index. This suppression is diminished in SCZ and the 
entity of this decrease correlates with cognitive decline in patients (Potter et al., 
2006). 
 
Quantitative EEG (qEEG) during spontaneous resting-state has failed to show 
relevant differences in ARMS and in FEP subjects. On the other hand, such 
findings are common in chronic patients so they are likely to emerge in 
advanced stages of illness as a tardive sign of cognitive decline or possibly 
depend on pharmacological treatment, making them unlikely candidates as 
endophenotypes (Ranlud et al., 2014). Some data suggest that abnormalities 
are only present in HR subjects who went on to develop the disorder, whereas 
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the remaining did not differ from healthy control subjects (Bodatsch et al., 
2011). 
 
EEG sleep studies have only recently begun to emerge in the endophenotype 
literature. These will be analysed in major depth in the following section, given 
the specific focus of my work. 
 
5. THE NEUROPHYSIOLOGY OF SLEEP  
 
5.1. The Wake/Sleep Cycle 
  
Sleep is thought to reflect a state of sensory disconnection from the 
environment and the reduction of functional cortico-cortical/cortico-thalamo-
cortical connectivity is hypothesized to result in the restriction of consciousness 
and altered transmission of information within the brain (Tononi 2004). Sleep 
can be subdivided in Rapid Eye Movement (REM) and non-REM (NREM) sleep 
depending on the presence or absence of fast, intermittent ocular movements. 
The subdivision of sleep stages is based on polysomnographic recordings 
which combine electromyography (EMG) and electrooculography (EOG) to 
EEG. Despite the reduction in functional connectivity during NREM, the brain is 
still According to the latest AASM revision, NREM sleep is subdivided in three 
stages, each of which presenting its own features (Iber et al., 2007). 
 
NREM Stage 1 (N1) is defined by low-voltage EEG with alternating alpha and 
theta frequencies, slow eye movements and preserved muscle tone. During this 
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stage vertex waves can be observed as brief, sharp transients with maximum 
negativity over central and – to a lesser degree – frontal midline derivations.  
 
Theta and medium voltage delta waves are typical of NREM Stage 2 (N2). 
However, the stage is defined by the presence of K-complexes and sleep 
spindles. Whereas the former are bi- or triphasic elements characterized by a 
brief, negative component and a secondary slow wave, the latter are fusiform 
sinusoids that are most prominent over central midline regions. Their frequency 
is in the Sigma range (12-16 Hz) and they occur in short bursts of waxing and 
waning rhythmic activity with amplitude usually between 20 and 100 µV. 
 
NREM stage 3 (N3) – often referred to as Slow-Wave Sleep (SWS), Delta Sleep 
or simply “deep sleep” –  is defined by the presence of a slow, highly 
synchronous delta activity that can be observed in at least 20% of the recorded 
epoch. Spindles and K-complexes can still be seen, although Delta bursts, i.e. 
sequences of at least two high-voltage delta waves, are more typical of this 
stage. 
 
REM sleep typically occupies 20–25% of total sleep and can be identified by 
REMs associated with loss of muscle tone and a fast, low-voltage, 
desynchronized EEG. Eye movements and muscle twitches correspond to the 
phasic stage of REM sleep as opposed to the intervening tonic stages. 
Combined transcranial magnetic stimulation (TMS)–scalp EEG techniques have 
recently confirmed a similarly widespread and differentiated pattern of cortical 
activation in REM sleep and wakefulness. This clearly distinguishes REM sleep 
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from other stages of sleep in which thalamocortical circuits progressively lose 
their capability of producing the complex responses to TMS observed in 
wakefulness (Massimini et al., 2010). Furthermore, phasic bursts have been 
shown to progress from the pontine nuclei to the lateral geniculate bodies and 
terminate with an activation of the occipital cortex. These currents of electrical 
activity, commonly referred to as ponto-geniculo-occipital waves (PGO) trigger a 
visual stream of information in the absence of external stimuli, and have as 
such been conceptually correlated to the emergence of the complex visual 
hallucinations found in dreams. Although typically found in REM sleep, they 
have been proposed amongst other overlapping phenomena to reflect a ‘covert’ 
REM sleep activation across other stages of sleep (Nielsen, 2005). According to 
this hypothesis, conscious subjective experiences outside of REM sleep can be 
explained by the co-occurrence of fundamental aspects of REM sleep during 
NREM periods. 
 
Human sleep has long been considered a global phenomenon, coordinated by 
specialized and diffuse networks of neurons that modulate the activity of the 
whole-brain. However, depth recordings have recently begun to show that 
wakefulness and sleep are part of a continuum resulting from the complex 
interaction between diffuse neuromodulatory systems and intrinsic properties of 
different thalamocortical modules (Sarasso et al, 2014). The brain’s continuous 
cycling between wakefulness and different stages of sleep has been proposed 
to reflect the balanced activity between the so-called ‘REM-off cells’ 
(serotonergic dorsal raphe nucleus and noradrenergic locus coeruleus neurons) 
and ‘REM-on cells’ (pedunculopontine tegmental neurons). REM sleep is 
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sustained by the activity of dopamine- and acetylcholine-releasing neurons and 
suppressed by the firing of noradrenergic, serotonergic and histaminergic 
neurons. The observed shift towards a highly active albeit closed system is 
cholinergically driven but also mediated by mesolimbic dopamine, which 
possibly contributes to the generation and motivational content of dreams. 
 
Lack of coordination between activation and dampening of regulation systems 
might lead to the generation of dissociated stages of sleep (DSS), shared 
among physiological and pathological conditions. Intermediate Sleep (IS) is a 
transitional EEG pattern in which features of REM sleep are combined with k-
complexes and spindles that typically define N2. IS represents 1-10% of 
physiological sleep in healthy subjects but it can increase in pathological 
conditions. More recently IS has been conceptually expanded to incorporate all 
those conditions in which different features of sleep are recorded 
simultaneously or with rapid oscillations; such patterns are grouped under the 
term DSS. These supposedly depend on abnormalities on various levels of 
sleep stage control systems so they can present as REM without atonia 
(RSWA), or without ocular movements (RSWR), or also as slow waves sleep 
with rapid eye movements (NRSWR) (Mahowald, 2011). 
 
5.2. Physiological origin of Sleep Spindles 
	  
In humans, spindle activity is highly variable. A large number of studies 
observed two types of spindles which differ in terms of distribution and 
frequency; fast spindles are more easily observed in central and parietal regions 
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whereas slow spindles are typically recorded over frontal cortices bilaterally. 
The latter tend to occur after the former, although some overlap can be found. 
Furthermore, the majority of events appears to be limited to small cortical 
regions whereas global spindles are relatively rare. This theory was confirmed 
by a recent study in which a low correlation was found between cortical scalp-
recorded spindles and hippocampal spindles recorded with depth electrodes in 
epileptic patients. Similar results had been reported from insular recordings. 
The authors suggest that spindle generation is under a strong local cortical 
influence, contributing to the view of sleep as a local phenomenon and 
challenging the view of sleep spindles as synchronous phenomena (Frauscher 
et al., 2015). 
 
Sleep spindles are generated in the thalamic reticular nucleus (TRN), a thin 
sheet of cells surrounding the anterolateral part of the thalamus (Halassa et al., 
2011). The TRN is entirely composed of a rather heterogeneous population of 
parvalbumin immunoreactive GABAergic neurons (PV+) (Celio, 1990). The TRN 
is a thin thalamic nucleus which receives both thalamocortical and 
corticothalamic projections which contribute to its reticular aspect. The 
brainstem and forebrain also project to the TRN, through 
monoaminergic/cholinergic and GABAergic pathways respectively. GABAergic 
TRN neurons thythmically discharge on thalamic neurons which project to the 
cortex. This activity determines depolarization potentials across vast neuronal 
regions recorded on the scalp as spindles, high-frequency bursts that also 
induce a post-synaptic inhibitory potential in thalamic relay nuclei. 
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During wakefulness, the tonic activity of the TRN inhibits the background activity 
of thalamocortical relay nuclei, possibly under the influence of frontolimbic 
attentive circuits. TRN activity is also related to the “lateral” inhibition operated 
by stimulus-activated neurons which optimize response to sensory stimuli. 
Reduced efficiency of this system has been hypothesized to determine a 
reduction of signal-to-noise ratio, thereby impairing the precision of thalamic 
relay mechanisms (Ferrarelli e Tononi, 2011). 
 
6. ABNORMAL SLEEP ELECTROPHYSIOLOGY IN SCHIZOPHRENIA 
 
6.1. Sleep spindle deficit in Schizophrenia: State of the art  
 
The study of sleep during EEG yields a unique window to study the physiology 
of brain function but also its pathology, given the abolition of wakefulness-
related confounding factors such as fluctuating attention, diminishing motivation 
or cognitve faculties and interfering symptoms (Ferrarelli et al., 2007). 
Sleep/wake rhythm abnormalities or the architecture of sleep itself have long 
been recognized as a symptom of SCZ that can at times predate its onset. REM 
sleep abnormalities have often been reported, both in terms of latency and 
duration of single sleep cycles or total sleep duration. Furthermore, 
abnormalities of slow waves during sleep, reductions of N2, a general reduction 
of Delta rhythms and SWS deficit have all been reported across studies, 
although results tend to vary considerably (Gardner et al., 2014). 
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Spindle density and Integrated Spindle Activity (ISA) were recently found to be 
reduced on prefrontal, centroparietal and temporal regions (Ferrarelli et al., 
2007 e 2010). The activity of spindles and slow wave activity was studied over a 
whole night of sleep in a group of 49 SCZ patients, comparing findings with the 
EEG of 20 subjects treated with antipsychotics for other psychiatric diagnoses 
(Major Depression, Bipolar Disorder, Post-Traumatic Stress Disorder, Panic 
Disorder and Generalized Anxiety Disorder) and 44 healthy control subjects. 
 
SCZ subjects showed a decreased amplitude of spindles in centro-parietal 
regions and duration in prefrontal regions compared to control subjects. In this 
sample, slow waves rhythm was unchanged across the three populations. The 
amount of SWA is considered a reliable measure of brain function, given its 
independence from complex cellular interactions and the balance between 
excitatory and inhibitory mechanisms, both local and long-range. The amount of 
SWA during sleep has been found to be reduced in SCZ patients, although 
some findings suggest the opposite may be true (Keshavan,2011). Structural 
MRI and electrophysiological features were compared in SCZ and healthy 
control subjects, yielding a correlation between reduced volume in the 
mediodorsal thalamic nucleus (MD) and reduced number of recorded spindles 
in patients (Buchmann et al., 2014). Furthermore, the origin of sleep spindle 
currents identified on the prefrontal cortex was found to be reduced and a 
correlation of the deficit with impaired performance on cognitive tasks suggest 
an involvement of thalamocortical circuit dysfunction in the cognitive decline that 
is commonly fobserved in SCZ patients (Buchmann et al., 2014). 
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Sleep spindle deficits have been confirmed by an independent group which 
compared patients on antipsychotic treatment with different diagnoses and 
found impaired spindle activity only in SCZ patients (Wamsley et al., 2012). A 
negative correlation was recently reported between spindle density and cortical 
Glutamate/Glutamine (Glx) levels measured with magnetic resonance 
spectroscopy in 20 healthy subjects (Figure 6.1 A). In the same study, a 
magical ideation scale was used as proxy for schizotypal personality traits, 
yielding an inverse correlation with spindle density (Figure 6.1 B) (Lustenberger 
et al., 2015). 
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Figure 6.1 Correlation between fast spindle density (14.25–14.75 Hz) and (A) magical ideation score and (B) 
thalamic glutamine and glutamate levels corrected for CSF. Topographical distribution of r values is plotted on the 
planar projection of the hemispheric scalp model with negative correlations reflected in blue. White dots indicate 
significant electrode clusters after controlling for multiple comparisons. The scatter plots further demonstrate the 
significant correlation for the highlighted electrode clusters (Lustenberger et al., 2015). 
 
One study recorded sleep EEG data of nine adolescents diagnosed with an 
Early Onset Schizophrenia (EOS) and compared data with a sample of age- 
and gender-matched healthy control subjects. Affected individuals had a low 
overall density that was more pronounced over centroparietal and temporal 
regions (see Figure 6.2). The deficit was marked in the 13,75 - 14,5 Hz 
frequency range. Furthermore, a negative correlation was observed between 
mean sleep spindle density and severity of positive symptoms. Therefore, 
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spindle density appears a useful candidate to aid the diagnostic process of 
SCZ, not only in adults but also in adolescent patients (Tesler et al., 2015). 
 
 
Figure 6.2 Topgraphic distribution of spindle density in patients with Early Onset 
Schizophrenia (EOS) and Healthy controls. The figure shows topographical distibution of 
spindle density during the first hour of NREM sleep for the 13.75 – 14 Hz frequency band in (a) 
9 EOS subjects (b) 15 healthy controls (c) relationship between the two samples (d) 
corresponding statistically significant values.  
 
Another study conducted on 16 chronic, medicated SCZ subjects confirmed a 
marked decrease of sleep spindles and impaired sleep-dependent 
enhancement of memory in affected individuals (Göder et al., 2015). These 
findings are in line with those of another group that recently reported significant 
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N2 spindle deficits in 15 newly diagnosed, antipsychotic-naïve patients with 
SCZ (Manoach et al., 2014). In this sample spindle activity correlated with 
positive symptoms and IQ estimates across groups.  
 
However, one recent study on the sleep of 10 First-Episode, drug-naïve young 
adults diagnosed with SCZ failed to observe differences in spindle density. An 
excess of IS has been reported in several studies of SCZ compared to healthy 
control populations, although a recent study confirmed its presence but not at 
significant levels (Guénole et al., 2014). The authors attribute such difference to 
the examined sample, given that drug-naïve patients had never previously been 
tested so observed abnormalities could be enhanced by medication. An 
increase of RSWA was first reported in this study, which had previously been 
reported in patients with Parkinson’s Disease, Lewy Body Dementia, 
Narcolepsy and during treatment with antidepressant and hypnotic drugs. 
 
6.2. Neurophysiological bases of observed abnormalities 
 
The cerebral cortex is composed of 2 main types of cells: excitatory pyramidal 
cells which project to other parts of the cortex and non-pyramidal cells, including 
interneurons. These are small neural cells that communicate through inhibitory 
synapses and which are supposedly critical for the formation of oscillations.  
GABAergic interneurons are usually connected to several pyramidal cells, 
creating multiple synapses with each and exerting a strong influence on their 
excitability. The coordinated modulation of membrane potentials by 
interneurons synchronizes pyramidal cells activity and the transformation of 
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electrical activity into oscillations: the longer the inhibition, the slower the 
oscillation. Over the past few years, the role of the thalamus in coordinating 
distributed cortical regions through rhythmic interactions has been progressively 
clairified. As an example, during visual attention processing in primates, the 
thalamic pulvinar nucleus coordinates activity in regions of the visual cortex by 
means of alpha band synchrony which is a performance-correalted 
physiological measure. Neuroanatomical imaging shows that the thalamus is 
organized in parallel pathways that independently reach the neocortex. Such 
property makes the thalamus a possible starting point for central abnormalities, 
leading to wide-scale brain effects from a single, restricted starting point (Cohen 
et al., 2015). 
 
GABA receptor dysfunction in SCZ patients is strongly supported and post-
mortem studies reveal a loss of GABA markers in several cortical regions 
(Gonzalez-Burgos e Lewis, 2008). A specific subtype of GABAergic cells that 
are Parvalbumin-positive (PV+) appear to correlate with the production of 
gamma and theta frequencies (Moran e Hong, 2011). PV+ interneurons appear 
to be involved in various compex functions such as perceptive discrimination 
and attention and in the regulation of cerebral plasticity and in learning. The 
nature of identified abnormalities can vary from region to region and in various 
different subregions intraindividually. Disorders of GABAergic function could 
therefore casuse complex behavioural dysfunctions such as those observed in 
the highly variable syndromic presentation of SCZ patients (Benes et al., 2015). 
One study revealed that the manipulation of a single receptor with substances 
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influencing interneuronal function could modifiy cerebral rhythms in a frequency-
specific and region-specific way (Whittington at al., 2011). 
 
On a neuroanatomical level, many distinctive abnormalities of SCZ appear to 
contribute to impaired SWA, among which the most relevant are: enlargement 
of ventricles, a reduction of cortical thickness and a volumetric reduction of 
associative cortices and of the thalamus (Gardner et al., 2014). Ketamine, a 
non-competitive NMDA receptor antagonist, can induce behavioral 
modifications that resemble SCZ, altered glutamatergic transmission can be 
hypothesized to reflect NMDA receptor blockade, of thalamic GABAergic 
interneurons and the TRN particularly, leading to disinhibition of cortical Glu 
release. Given that a neuronal subtype with specific biophysical properties can 
be found in this nucleus, hyperpolarization could determine its activation and 
increased EEG discharge recorded as delta band, the quantity of which has 
been associated to cognitive deficits in SCZ (Cohen et al., 2015). Whereas 
psychopharmacological management of SCZ has commonly involved D2-
receptor blockade, new studies on GABAergic and glutamatergic systems and 
reciprocal interactions may lead to the development of future therapeutic 
targets. One recent study (Wamsley et al., 2013) found an increased spindle 
activity in SCZ patients after administration of eszopiclone, a GABAergic 
hypnotic. Other studies had previously shown an increase in spindle density 
and memory improvement in healthy volunteers, whereas benzodiazepine use 
leads to reduced SWR acting on GABA-A receptors (Gardner et al., 2014). 
Multireceptor agents or specific polypharmacy could act by increasing the 
interneuronal discharge in order to specifically address only regions that are 
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functionally disrupted in the disorder. Along this line, glycine administration oe 
reduction of its synaptic reuptake by administration of a competitive antagonist 
such as bitopertin could improve negative symptoms, although results are 
contradictory (Cohen et al., 2015). 
 
 
Figura 6.3 Circuits involved in the generation and synchronization of distributed networks during NREM sleep. 
The major circuits involved in the generation of NREM sleep include the Cortex, Thalamus and Hippocampus. Cortical 
and Hippocampal neurons are pyramidal cells of the deep player L5 and local interneurons (mainly PV+ basket cells). 
Thalamic neurons are thalamocortical cells and inhibitory cells of the TRN. Top: Sleep circuits in Healthy Control (HC) 
subjects. Cortical local currents in L5 and L6 deep layers are the major contributors to the generation of Slow waves 
(blue lines) Cortical efferences reach the Thalamus, where thalamocortical cells and the TRN generate spindles. 
Bottom: Sleep circuits in Schizophrenia (SCZ) patients, where cortical, thalamic and hippocampal abnormalities could 
influence neuronal activity during NREM sleep (Gardner et al., 2014).  
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7. SLEEP IN FIRST-DEGREE RELATIVES OF SCHIZOPHRENIA PATIENTS 
 
7.1. Background 
 
During sleep, the brain structures responsible for the gating of sensory 
information (thalamus) and the processing and response to input (cerebral 
cortex) are active and reciprocally communicating to produce the major 
spontaneous EEG oscillations of sleep: slow-waves and sleep spindles. These 
oscillations are a sensitive indication of the normal function of the brain and, 
since they occur during sleep, they do not require effort, attention or 
concentration from the subject. Sleep spindles, a defining characteristic of stage 
2 sleep, are brief powerful bursts of synchronous 12–15 Hz neuronal firing in 
thalamo-cortical networks, which reach peak density late in the night (De 
Gennaro et al., 2000). Spindles induce massive influxes of calcium ions into 
cortical pyramidal cells, which are believed to trigger intracellular, calcium-
dependent mechanisms required for synaptic plasticity (Sejnowski and 
Destexhe, 2000). Slow wave activity has been correlated with overnight 
improvement of motor procedural learning (Huber et al., 2004) and 
accumulating evidence suggests that sleep spindles mediate sleep-dependent 
consolidation of both procedural and declarative memory (Fogel and Smith, 
2011). Our associate laboratory at the University of Wisconsin successfully 
identified reductions in both spontaneous EEG oscillations during sleep (sleep 
spindles) and reductions in functional connectivity (assessed by TMS-EEG 
during wakefulness) in subjects with schizophrenia (Ferrarelli et al. 2007; 
Ferrarelli et al. 2008). This deficit may reflect an abnormality in the function of a 
specific brain structure, the thalamic reticular nucleus, that is also involved with 
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regulating attention and brain processing of sensory information (“gating”) 
during wakefulness. During sleep, the TRN plays a fundamental role in 
generating and maintaining spindles through cortico-cortical and cortico-
thalamic loops. These findings are unique in the field and are particularly 
important as they implicate a specific brain structure and provide a readily 
measurable objective finding associated with illness. These preliminary findings 
have already been replicated by another group in unmedicated subjects with a 
recent diagnosis of any psychotic disorder (Keshavan et al., 2011), but mixed 
reports exist in the few studies on very small sample sizes which had previously 
reported increased (Hiatt et al., 1985) or unmodified (Van Cauter et al., 1991; 
Poulin et al., 2003) spindle counts when compared to healthy control subjects. 
 
In order to clarify the role of sleep spindles and to validate this marker as a a 
putative endophenotype of the disorder, we conducted a single-site, controlled, 
un-blinded study to examine changes in the activity of the sleeping brain in 
First-Degree Relatives (FDR) of SCZ subjects. 
 
7.2. Materials and method 
 
7.2.1 Experimental sample 
 
FDRs were recruited primarily by referral from patients or from their ill relative’s 
physician. They were given an information sheet and clean copy of the Informed 
Consent form. After a complete description of the study, written informed 
consent was obtained. Healthy control subjects had no major medical, 
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neurological, psychiatric or sleep disorder. They were selected for age and 
gender to allow adequate pair matching with the FDR group. 
 
7.2.2 Inclusion/Exclusion Criteria 
 
Inclusion Criteria (all subjects): Ability to provide written consent prior to 
admission; Ability to understand and speak Italian; Age of ≥ 16 years and ≤ 65; 
good general health determined by the investigator on basis of medical history, 
physical and neurological exam; a first-degree relative (FDR) with a diagnosis of 
Schizophrenia. 
 
Exclusion Criteria (all subjects): Diabetes requiring insulin treatment; A serious 
heart disorder; A diagnosis of cancer within the previous 3 years; Clinically 
significant abnormalities on pre-study physical exam or physician evaluation; 
Subjects who met available criteria for alcohol/drug abuse problems within the 
previous six months or were using illegal drugs. Subjects who regularly 
performed night or late evening shift work or who traveled with time zone shifts 
>3h in the 3 weeks prior to participation. 
 
Additional Criteria for the healthy control group: Control subjects did not have a 
current or past diagnosis of any Sleep Disorder; Control subjects were good 
sleepers without insomnia or excessive sleepiness (based on clinical interview 
and sleep rating scales); Control subjects did not have a current or past 
psychiatric diagnosis OR any First-Degree Relative with a history of major 
psychiatric disorders; Comparison subjects were not taking any medication with 
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psychotropic effects (e.g. antipsychotics, antidepressants, anxiolytics, 
psychostimulants, antihistamines or beta blockers - based on subjective reports 
and clinician judgment). 
 
7.2.3 Study procedure 
 
All participants were interviewed to obtain a complete psychiatric, neurologic 
and medical history and to rigorously exclude any psychiatric diagnosis based 
on DSM-IV-TR criteria (APA, 2000). All participants completed a battery of 
tests, the results of which are reported along with demographic characteristics 
of the experimental sample in Table 7.1: 
 
(i) The Brief Assessment of Cognition in Schizophrenia (BACS, Keefe et al., 
2004), which provides a brief, reliable and valid test of global 
neuropsychological function that has already been used in research on SCZ 
endophenotype research (Hill et al., 2013). Tests included in the BACS are the 
following: list learning, digit sequencing, verbal fluency, token motor task, 
symbol-coding and Tower of London. Normative values have been established 
using the Equivalent Scores method in order to enable comparison with other 
neuropsychological tasks commonly used in the assessment of the Italian 
population (Anselmetti et al. 2008).  
 
(ii) Pittsburgh Sleep Quality Index (PSQI, Buysse et al., 1989) and Epworth 
Sleepiness Scale (ESS, Johns et al., 1991) were employed to assess subjective 
sleep quality and the presence/absence of relevant disorders. Participants’ self-
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reports were compared with available normative values (PSQI good sleeper <5; 
ESS normal ≤10) 
 
(iii) Peters et al. Delusions Inventory (PDI). This self-administered test is 
commonly used to assess psychosis proneness in the general population. 
Participants completed the 21-item Italian version (Preti et al., 2002). PDI items 
address unusual subjective experiences and beliefs in the general population 
with questions in dubitative form. The optimal cut-off point for psychotic subjects 
has been set at 8, and the test has been shown to reliably distinguish between 
subjects with psychosis and subjects with other forms of mental disorder such 
as anxiety spectrum disorders. Finally, participants completed a revised version 
of the Launay-Slade Hallucination Scale (LSHS–R, Vellante et al, 2012). The 
questionnaire is commonly used in research settings to assess the prevalence 
of hallucinatory experiences in healthy subjects. 
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Characteristics FDR CONTROL 
   
Age (years) 48.5 ± 14.2 49,8 ± 12.7 
Gender (male : female) 8 : 8 8 : 8 
Education (years) 13.8 ± 3.9 / 
   
PSQI total score 3.3 ± 2.6 / 
ESS total score 6.6 ± 2.7 / 
LSHS-R total score 3.9 ± 5.4 / 
PDI total score 2.9 ± 2.8 / 
   
BACS list learning 49,6 ± 7 / 
BACS digit sequencing 22 ± 3,2 / 
BACS token motor task 67,3 ± 21,5 / 
BACS verbal fluency 46,2 ± 14 / 
BACS Tower of London 15,1 ± 4,7 / 
BACS symbol-coding 52,5 ± 9,8 / 
   
Table 7.1. Clinico-demographic characterization of the experimental sample  
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7.2.4 Sleep EEG recording 
 
Patients were recruited at the Department of Mental Health of the San Paolo 
Hospital in Milan, Italy. EEG recordings took place in the same building at the 
Neurology II Unit - Regional Epilepsy Center - Sleep Medicine. All data were 
analysed at the Department of Clinical Sciences of the University of Milan. 
 
Subjects were asked to arrive at the lab ~2 hours before their usual time of 
falling asleep. Whole-night high-density EEGs were performed with 256-
electrode nets designed to improve electrode contact with the scalp, thereby 
enabling long-duration recordings (EGI, Eugene, Oregon, United States; Figure 
7.1). After calibrating the equipment, standard baseline recordings were 
obtained while the subject was awake (resting wakefulness with eyes open and 
eyes closed). The subject was then accomodated in a sleep suite and allowed 
to sleep at the self-reported bedtime until morning. 
 
	  52	  
 
 
 
 
 
 
 
 
Fig. 7.1 High-density (Hd)-EEG 
montageis Dense-array scalp EEG 
recording systems consist of pre-
cabled nets connected to a digital 
amplifier. The number of electrodes 
used can vary from 32 to 256 in 
commercially available nets. The high 
density of electrodes increases 
spatial accuracy, thus favouring an 
adequate, real-time source 
localization of the cortical signal, or 
detection of hidden EEG features. 
However, the relevant amount of data 
collected requires sophisticated post-
processing analyses by experienced 
technicians to achieve significant 
results. Current clinical applications 
are limited to the precise presurgical 
identification of epileptic foci. 
Nontheless, the tool is suited for 
countless brain research applications, 
particularly in the field of sleep 
pathophysiology. Many studies have 
addressed specific sleep-related 
elements such as delta waves, 
spindles and K-complexes by means 
of hd-EEG, expanding the available 
knowledge over their physiological 
role (Pisarenco et al., 2014)
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7.2.5 EEG data analysis 
 
EEG signal was band-passed (0.5–50 Hz) and digitized at 500 Hz. RAW files 
were visually inspected in the EGI NetStation native software and then 
transferred to MATLAB (The MathWorks, Inc, Natick, Massachusetts, United 
States) environment for analysis. An 8-channel bipolar montage system was 
created for sleep staging [Right Eye Oculogram (REOG), Left Eye Oculogram 
(LEOG), F3-A2, F4-A1, C3-A2, C4-A1, O1-A2 and O2-A1]. I scored the data in 
30 second epochs according to the American Academy of Sleep Medicine 
criteria, under the supervision of an expert (Iber et al., 2007). Alice Sleepware 
(Philips Respironics) was used and a csv file with scoring information was then 
created for use in Matlab, where the EEGlab toolbox (Delorme and Makeig, 
2004) was implemented with customized scripts developed for this study. Clear 
artifacts were visually excluded from sleep staging during the scoring 
procedure. 
 
A previously published artifact removal algorithm was used to reject 30-s 
epochs which exceeded thresholds based on the mean power for each channel 
in 0.8- to 4.48-Hz and 20- to 30-Hz bands (Ferrarelli et al., 2010). Signals were 
then re-referenced to the average for all included channels. Power spectral 
density of non-REM epochs was then computed with a 0.16 Hz bin resolution, 
fast-Fourier transform routine (Welch’s averaged modified periodogram with a 
Hamming window, averages of five 6-second epochs). Approximately 1 – 3 
undetected bad channels were then manually excluded for each subject after 
visual inspection. 
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An automated algorithm was then used to detect sleep spindles, as shown in 
Figure 7.2. Duration and amplitude of each detected spindle were measured. 
Spindle density and Integrated Spindle Activity (ISAs) were then calculated for 
each channel as follows: 
 
(i)  Spindle Density = number of spindles / minutes of NREM sleep 
(ii) ISAs = Integration of absolute Amplitude value of each spindle / its duration 
 
To characterize spindles in slow (12–14 Hz) and fast (14–16 Hz) frequency 
ranges, spindle parameters were then also calculated from NREM data filtered 
in these two frequency bands. 
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Figure 7.2 Spindle detection procedure. NREM epochs were band-pass filtered between 11 and 16 Hz and the 
amplitude of the rectified filtered signals were used as time series for each channel. Because signal amplitude varied 
significantly across channels, thresholds relative to the mean amplitude of each channel were used. The lower threshold 
was set at two times the mean amplitude of the channel signal and the upper threshold was set at eight times the mean 
amplitude. Whenever an amplitude fluctuation exceeded the upper threshold, a spindle was detected. Points preceding 
or following (≥0.25 second) this maximum when amplitude dropped below the lower threshold were considered as 
beginning and end. Green crosses indicated detected spindles; vertical dashed lines enclose detected spindles. 
 
7.2.6 Statistical analyses 
 
To compare demographic characteristics, sleep architecture, and EEG power 
between groups, unpaired t-tests were performed. Group differences in spindle 
density, duration and ISAS were assessed with Mann-Whitney U / Wilcoxon 
Ranks Sum tests. Cohen’s d was also calculated for spindle parameters that 
differed between groups. Finally, we performed Spearman’s rank correlation 
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analyses between spindle parameters and available neurocognitive tests and 
measures of psychosis proneness. 
 
7.3. Results 
 
7.3.1 Sleep Architecture 
 
Sleep architecture differences between the two groups are shown in Table 7.2 
Percentage of REM, N1 and N3 sleep differed significantly between groups. 
FDRs showed average 6% reductions of both REM and SWS sleep in favour of 
a > 10% increase of N1. Sleep efficiency was reduced by 9% in FDRs whereas 
TST presented a 25% reduction in FDRs compared to the healthy control group. 
Sleep latency, REM latency, WASO and N2 did not differ between groups. 
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Sleep variable FDR CONTROL t-test 
   t p 
Total sleep time (min) 274,3 ± 77,3 368,1 ± 36,2 -4,390 0,0002** 
Sleep latency (min) 30,8 ± 26,3 26,2 ± 8,8 0,662 n.s. 
REM latency (min) 146,4 ± 64,2 117,5 ± 36,1 1,556 n.s. 
Total waking time (min) 32,2 ± 13,5 23,1 ± 7,6 2,354 0,01* 
Wake after sleep onset 
(min) 
95,6 ± 36,9 86,3 ± 34,8 0,735 n.s. 
Sleep efficiency 67,8 ± 13,5 76,9 ± 7,5 -2,354 0,01* 
% Stage 1 14.2 ± 10,9 3,6 ± 2,3 3,821 0,001** 
% Stage 2 51,7 ± 13,5 49,7 ± 7,8 0,651 n.s. 
% Stage 3 19,4 ± 5,6 25,7 ± 8,7 -2,406 0,03* 
% REM 14,6 ± 7,1 20,9 ± 3,8 -3,152 0,004** 
Table 7.2 Sleep macrostructural differences between the two groups. *Significant values at p < 0.05 **Highly 
significant values at p < 0.01 
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7.3.2 EEG Power Analysis 
 
EEG power during NREM sleep was calculated between 0.5 and 40 Hz for the 
two groups over the whole night and during the first cycle of sleep (Figure 7.3). 
Significant group differences in the spindle range were observed during the first 
cycle (12–16 Hz), with a nonsignificant trend emerging for the whole night. 
 
 
 
 
Figure 7.3 EEG spectral power plots in First-Degree Relatives (FDR) of Schizophrenia patients and Healthy 
Control (HC) subjects. Left: The plots show spectral power in the broad 0 – 40 Hz range over the whole night (top) 
and during the first cycle (bottom). Right: Mean group differences restricted to the sigma power range. Power deficits in 
FDRs were markedly visible during the first cycle (bottom) but they were not restricted to spindle range, given significant 
differences for frequencies <14 Hz. 
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7.3.4 Spindle Analysis 
 
An initial analysis was performed for spindle density, duration and integrated 
activity in the 12–16 Hz frequency range for the whole night. The topography of 
each parameter was similar between groups, with peaks in prefrontal and 
centroparietal areas. Spindle density (Figure 7.4.1) and duration (Figure 7.4.2) 
in these regions largely overlapped between groups. No difference in slow / fast 
spindle duration or density was observed between the two groups. 
 
 
Figure 7.4.1. Whole-night sleep spindle density in First-Degree Relatives (FDR) of Schizophrenia patients and Healthy 
Control (HC) subjects. Topographical distribution of spindle activity in both groups confirms validity of the methodology 
employed. No statistically significant difference could be observed between FDR and HC groups in the whole sigma 
frequency range. Further analyses (topographies not shown) failed to detect significant  between-group differences also 
for fast and slow spindle frequency ranges. 
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Figure 7.4.2. Whole-night sleep spindle duration in First-Degree Relatives (FDR) of Schizophrenia patients and Healthy 
Control (HC) subjects. No statistically significant difference could be observed between FDR and HC groups in the 
whole sigma frequency range. Further analyses (topographies not shown) failed to detect significant  between-group 
differences also for fast and slow spindle frequency ranges. 
 
A significant deficit of Integrated Spindle Activity compared to healthy subjects 
was clearly present in First-Degree Relatives (Wilcoxon Ranks Sum p<0.05) in 
prefrontal and centroparietal regions (Figure 7.5, top row). Additional analyses 
were performed for slow (12–14 Hz) and fast (14–16 Hz) spindles. Integrated 
Spindle Activity was significantly reduced in centroparietal regions for both 
frequency ranges (Wilcoxon Rank Sum, p<0.05). 
 
Given the presence of significant power differences during the first cycle, all 
spindle parameters were then re-analysed but restricted to the first cycle. Again, 
topographical distribution of spindles peaked in prefrontal and centroparietal 
regions for both groups. Spindle density and duration overlapped between 
groups, yielding no significant difference. The significant ISAS deficit observed 
in the FDR group in the whole-night analysis was also confirmed for the first 
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cycle (Wilcoxon Ranks Sum p<0.05) in prefrontal and centroparietal regions 
(Figure 7.5, central row). 
 
Finally, the same parameters were re-analysed but restricted to whole-night N2, 
the stage of sleep that is defined by the presence of spindles. ISAS was 
confirmed in the FDR group (Wilcoxon Ranks Sum p<=0.05 ) in prefrontal and 
centroparietal regions (Figure 7.5, bottom row). Additional analyses were 
performed for slow (12–14 Hz) and fast (14–16 Hz) spindles. Integrated Spindle 
Activity was significantly reduced in centroparietal regions for both frequency 
ranges (Wilcoxon Rank sum, p<0.05).  
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Figure 7.5. Integrated Spindle Activity deficit in First-Degree Relatives (FDR) of Schizophrenia patients and Healthy 
Control (HC) subjects. Significant differences were observed between FDR and HC groups in the whole sigma 
frequency range for ISAS. The strength of this finding was confirmed over the whole night (Top), during the first cycle 
(Centre) and also whole-night NREM stage 2 sleep (Bottom).  Further analyses (topographies not shown) confirmed 
ISAS deficit in FDRs for both fast and slow spindle frequency ranges. White dots on right-sided topographies indicate 
electrodes showing significant differences between the two groups. 
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7.3.5 Effect Size of Integrated Spindle Activity deficit 
 
In order to determine the magnitude of the observed spindle deficit in First-
Degree Relatives, Cohen’s d was calculated for ISAs as a measure of Effect 
Size. Cohen’s d value ranged from an effect size equal to 0.99 for ISAs over the 
whole night to an effect size of 1.26 during the first cycle of the night. Cohen’s d 
value was 1.1 and 0.8 for slow and fast spindles over the whole night and 1.33 
and 1.1 respectively in the first cycle. 
 
7.3.6 Measures of neurocognition and psychosis proneness 
 
No significant correlation was observed between available neuropsychological 
tests and peak ISAs value. Spindle deficit also failed to yield any significant 
correlation with psychosis proneness scores in either the delusional thinking or 
hallucination scores. On the former scale, two subjects reached the lower 
threshold for psychsosis, whereas all others scored well below (Table 7.1). 
 
7.4. Discussion of main findings 
 
The main finding of this study is that First-Degree Relatives of subjects 
diagnosed with Schizophrenia have a partial deficit of Sleep Spindle Activity that 
can be summarized as a significant decrease of Integrated Spindle Activity with 
preserved physiology of Spindle Density and Duration. ISAs deficit was more 
pronounced during the first cycle of sleep and was confirmed for both fast and 
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slow spindle frequency ranges. To the best of our knowledge, this is the first 
study to evaluate this marker of thalamocortical function in a population of 
healthy, adult relatives of SCZ patients. 
 
In terms of Sleep Architecture, compared to available normative values for the 
40 - 60 years of age range (Ohayon et a., 2004), TST and REM% were the only 
parameters to be considerably reduced in the FDR sample. Indeed, Sleep 
latency was doubled and WASO was over three times the normative value 
(below 30 minutes) for both groups. Likewise, sleep efficiency was lower than 
expected (> 80%) for both groups. N1 was particularly reduced in our control 
population but close to norm in the FDR group. N3 was slightly increased in 
both samples and significantly lower in FDRs. This confirms one previous study 
in which SWS latency and duration variables were found to be reduced in SCZ 
patients and FDRs compared to healthy controls (Sarkar et al., 2010). N2 – the 
most relevant macrostructural value given the focus of this study on spindles – 
was in line with normative parameters and did not differ between groups. 
 
The possible effect of sleep architecture on our main finding was ruled out with 
adjunctive analyses on N2 and on the first cycle of sleep. Indeed, the most 
conspicuous effect of ISAS difference between the experimental samples was 
observed during the first cycle of the night. Here, the deficit was widespread 
whereas it was more specifically localized on centroparietal cortical regions on 
whole-night NREM and N2 analyses. Although age- and gender-matched SCZ 
subjects were not directly compared in this analysis, previous studies at our 
associate laboratory revealed that patients have marked deficits in fast spindle 
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duration (prefrontal), amplitude (centroparietal), number and integrated activity 
(both prefrontal and centroparietal) that appear to be independent of 
medication. 
 
Sleep spindles have been associated with neurocognitive performance in 
several studies (Keshavan et al., 2011; Wamsley et al.; 2012; Göder et al., 
2015). No relevant correlation was found in our sample of FDRs between ISAS 
and adjusted scores on the cognitive battery. Significant impairment of BACS 
scores had previously been reported in a large sample of SCZ relatives without 
a history of psychosis (Hill et al., 2013). However, when compared to available 
normative values (Anselmetti et al., 2008), our FDR sample did not show 
relevant impairment in most subtests. Whereas motor task results were below 
the threshold for pathological performance, all tests of memory, verbal fluency 
and executive function were within median values. 
 
To the best of our knowledge, only one study previously reported findings from 
the sleep of healthy, adult FDRs but only sleep architecture was addressed and 
no data on sleep spindle activity were reported (Sarkar et al., 2010). In the only 
previous study reporting sleep spindle activity of FDRs, recruited subjects were 
17 children and 2 siblings of patients with confirmed diagnoses of SCZ 
(Manoach et al., 2014). Almost 70% of these children (mean age 14 ± 4) had a 
lifetime history of other major mental disorders: Attention-Deficit/Hyperactivity 
Disorder (n = 5), Major Depression (2), Separation Anxiety Disorder (2), 
Oppositional Defiant Disorder (2) and Conduct Disorder (2). Furthermore, at the 
time of the study one child was taking amphetamine/dextroamphetamine and 
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another was taking sertraline. This type of FDR sampling is likely to be more 
informative about ultra-high risk than strictly endophenotype research, which 
should focus on subjects with shared liability who do not develop a disorder. 
Furthermore, even severe abnormalities of cortical thickness in siblings of 
VEOS have been found to normalize by the age of 20, suggesting that children 
and adolescent data cannot be easily bridged with findings in adults (Gogtay et 
al., 2007). Finally, the authors of the study acknowledged that the observed 
deficit might have been influenced by the relatively low mean IQ level found in 
their young population. Indeed, IQ has been found to correlate with sleep 
spindles (Fogel and Smith, 2011). Although IQ was not specifically tested in our 
sample, the general quality of the neuropsychological performance might be 
considered a surrogate for a normal IQ range. From this viewpoint, one might 
speculate that multiple factors contribute to quantified spindle activity, so that 
more pronounced deficits are found in samples in which low IQ and genetic 
vulnerability for SCZ are combined. 
 
ISA has been found to negatively correlate with positive symptoms and to 
clearly distinguish SCZ patients from both healthy subjects and patients with 
other major psychiatric diagnoses, making it a putative biological marker of the 
disorder. In terms of underlying pathophysiology, diffuse spindle deficits of SCZ 
patients have been attributed to dysfunction of the TRN spindle “generator”. 
Given the preserved physiology of spindle density and duration, the amplitude 
deficit observed in FDRs could reflect a partial dysfunction that does not impact 
on spindle number and duration but only size. On the other hand, smaller 
spindles could reflect a more general problem of thalamocortical connectivity, 
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leading to a recruitment of fewer thalamocortical fibers or an incomplete 
synchronization of cortical neurons which determines a discharge over relatively 
limited regions. 
 
8. SLEEP IN DRUG-NAÏVE, FIRST-EPISODE PSYCHOSIS PATIENTS 
 
8.1. Background 
	  
The thalamus has been proposed to play a major role in SCZ pathophysiology. 
One recent study confirmed several abnormalities of thalamic connectivity and 
began to clarify their relevance for several cerebral functions (Cheng et al., 
2015). In HR samples, thalamocortical connectivity deficits appear to predict the  
development of full-blown psychosis. Furthermore, the observed 
hyperconnectivity between thalamus and prefrontal cortices, sensorimotor areas 
and the cerebellum appear to correlate with symptom severity (Anticevic et al., 
2015). Sleep spindle deficits have been proposed to reflect aberrant 
thalamocortical connectivity given the thalamic origin of spindles (Ferrarelli and 
Tononi, 2011). However, most findings have been observed in chronic, 
medicated samples of SCZ patients and the characteristics at illness onset 
remain unclear. I report the preliminary findings from a subsample of drug-naïve 
subjects recruited during First-Episode Psychosis (FEP). 
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8.2. Materials and method 
 
8.2.1 Experimental sample 
 
FEP patients were recruited during their first hospitalization. After a complete 
description of the study, written informed consent was obtained. Healthy control 
subjects had no major medical, neurological, psychiatric or sleep disorder. They 
were selected for age and gender to allow adequate pair matching with the FEP 
group. 
 
8.2.2 Inclusion/Exclusion Criteria 
 
Inclusion Criteria (all subjects): Ability to provide written consent prior to 
admission; Ability to understand and speak Italian; Age of ≥ 16 years and ≤ 40; 
good general health determined by the investigator on basis of medical history, 
physical and neurological exam. 
 
Refer to Paragraph 7.2.2. for Exclusion Criteria and Additional Criteria for the 
healthy control group. 
 
8.2.3 Study procedure 
 
FEP patients followed the same experimental procedure decribed in chapters 
7.2.3 ! 7.2.6. All participants completed a battery of tests, the results of which 
are reported along with demographic characteristics of the experimental sample 
in Table 8.1: 
	  69	  
In this population, the following clinician-administered psychopathological rating 
scales were added to the evaluation:  
 
(i) The Positive and Negative Syndrome Scale (PANSS, Kay et al., 1987) was 
used to evaluate the presence and severity of typical SCZ symptoms. It is 
composed of 30 items, 7 of which for positive symptoms, 7 for negative 
symptoms, 16 for general psychopathology. 
 
(ii) The 21-item Hamilton Rating Scale for Depression (Ham-D, Hamilton, 1967) 
was used to quantify depressive symptoms. 
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Characteristics FEP CONTROL 
   
Age (years) 24,4 ± 3,6 24,3 ± 3,4 
Gender (male : female) 5 : 0 5 : 0 
Education (years) 13.8 ± 3.9 / 
   
PSQI total score 6.6 ± 2.7 / 
ESS total score 3.8 ± 3.5 / 
LSHS-R total score 21.8 ± 11.4 / 
PDI total score 11.4 ± 4 / 
PANSS total score 83.4 ± 13,4 / 
HAM-D total score 12,4 ± 8,1 / 
   
   
BACS list learning 40,2 ± 6,2 / 
BACS digit sequencing 22 ± 3,2 / 
BACS token motor task 58,4 ± 14,3 / 
BACS verbal fluency 46 ± 18,7 / 
BACS Tower of London 15,4 ± 6,2 / 
BACS symbol-coding 41,8 ± 8,1 / 
Table 8.1. Clinico-demographic characterization of the experimental sample 
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8.3. Preliminary Results 
 
8.3.1 Sleep Architecture 
 
Sleep architecture parameters in the two groups are shown in Table 8.2. The 
only significantly different value was the percentage of N3, which was 
diminished by roughly 9% in FEP patients. 
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Sleep variable FEP CONTROL t-test  
   t p 
Total sleep time (min) 354,6 ± 131,7 404,5 ± 35,2 -0,818 n.s. 
Sleep latency (min) 30,8 ± 26,3 26,2 ± 8,8 0,137 n.s. 
REM latency (min) 96,5 ± 26,3 142,7 ± 55,78 -1,675 n.s. 
Total waking time (min) 30,7 ± 23 16,2 ± 5 1,381 n.s. 
Wake after sleep onset 
(min) 
118,1 ± 82,2 46,2 ± 18,3 1,909 n.s. 
Sleep efficiency 69,3 ± 23 83,8 ± 5 -1,381 n.s. 
% Stage 1 8,6 ± 3,1 5,1 ± 2,6 1,892 n.s. 
% Stage 2 59,3 ± 10,8 49,8 ± 5,3 1,763 n.s. 
% Stage 3 14,7 ± 9,4 23,5 ± 7,6 -1,614 0,03* 
% REM 17,4 ± 8,2 21,5 ± 2,7 -1,061 n.s. 
Table 8.2 Sleep macrostructural differences between the two groups. *Significant values at p < 0.05 
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8.3.2 Spindle Analysis 
 
An initial analysis was performed for spindle density, duration and integrated 
activity for the whole night. The topography of each parameter was similar 
between groups, with peaks in prefrontal and centroparietal areas. No 
statistically significant difference in slow / fast spindle duration, density or 
integrated activity was observed between the two groups. 
 
8.4. Brief Discussion 
 
Preliminary findings seem to suggest that the spindle abnormalities observed in 
SCZ and confirmed – to a lesser extent – by my own work in healthy FDRs, are 
not clearly detectable in FEP patients. Enrolled subjects had a mean duration of 
untreated psychosis of about 2 months (9,8 ± 1,5 weeks) and had never been 
treated with antipsychotics or other psychotropic compounds. At first glance, the 
lack of significant difference in spindle activity between the two groups appears 
to support the view that thalamic / thalamocortical dysfunction in SCZ is related 
to chronicity or neurodegenerative aspects of the disorder rather than 
constitutive features that can be identified when symptoms first emerge. Indeed, 
three studies on antipsychotic-naïve patients with SCZ reported normal spindle 
density during N2 sleep. Although small, sample sizes were larger (11 for Poulin 
et al., 2003, 8 for Forest et al., 2007, 10 for Guénole et al., 2014). Unlike the 
present study, spindles were counted manually in the other studies. One recent 
study employing an automated algorithm for spindle detection reported spindle 
density and amplitude deficits in 15 newly diagnosed, antipsychotic-naïve 
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patients with a mean age of 28 ± 8 years (Manoach et al., 2014). The authors 
conclude their findings implicate thalamocortical circuit dysfunction before the 
onset of illness, in line with the recent evidence of reduced bilateral thalamic 
volume correlated with sleep disturbance in UHR adolescents (Lunsford-Avery 
et al., 2013). 
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9.	  TOWARDS	  A	  MOLECULAR	  CHARACTERIZATION	  OF	  THE	  SLEEP	  SPINDLE	  
DEFICIT	  ENDOPHENOTYPE	  
 
 
Sleep spindles could represent a highly unspecific marker of aberrant 
thalamocortical oscillatory activity that is shared by severe 
neurodevelopmental/neurodegenerative disorders (Manoach et al., 2015). 
Indeed, abnormal sleep spindle activity has been reported in many clinical 
conditions associated with cognitive impairment, from mental retardation 
(Shibagaki et al., 1982), phenylketonuria (De Giorgis et al., 1986), Williams 
syndrome (Bodizs et al., 2012) and autism (Tessier et al., 2015) to Parkinson’s 
disease with dementia (Latreille et al., 2015). However, spindle activity seems 
to adequately differentiate patients with SCZ from other patients with typical 
late-adolescence to young-adulthood onset disorders in psychiatry (Ferrarelli et 
al., 2010, Manoach, 2014). Progression of knowledge in this field will lead to a 
more profound understanding of the relationship between thalamocortical 
neurophysiology and complex interactions of cognitive, emotional and 
behavioural function. 
 
The work presented here appears to support the view that impaired spindle 
activity is an endophenotype of SCZ rather than a biomarker of the disorder. 
Furthermore, Slow Wave Activity must be accurately characterized in FDRs in 
order to clarify whether the mild impairment of spindle activity reflects an 
intermediate thalamic dysfunction or a peripheral dysfunction of neocortical 
activity. Preliminary findings in FEP patients must be interpreted cautiously 
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given the small sample and warrant immediate investigation in a large group of 
subjects. 
 
At the cellular level, the major sleep spindle pacemaker identified in the 
thalamus is Cav3.3, a voltage-dependent, T type Ca2+ channel (Astori et al., 
2011). Calcium channels control the rapid entry of Ca2+ into a variety of cell 
types and are therefore involved in both electrical and cellular signaling. T-type 
channels are activated by small membrane depolarizations and are known to 
generate burst firing and pacemaker activity. Intriguingly, the largest GWAS of 
SZ risk reported common variants in CACNA1I – a gene located on 
chromosome 12 in humans – which encodes for the alpha-1 subunit of Cav3.3 
(Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). 
 
Several line of evidence currently converge on the implication of PV+ neurons 
in SCZ. Post-mortem studies revealed GABAergic alterations, in particular in 
PV+ and calretin neurons in SCZ patients. Moreover, abnormal amplitude and 
synchrony of oscillatory activity, mainly frontal and at high (gamma) 
frequencies, have been found in SCZ, during task-related, spontaneous 
neuronal activity (Uhlhaas and Singer, 2013), as well as after transcranial 
magnetic stimulation (Ferrarelli et al., 2012; Rogasch et al., 2014). Gamma 
frequency (30–80Hz) oscillations require the synchronized inhibition of 
neighboring populations of pyramidal neurons by the subclass of cortical PV+ 
GABAergic interneurons (Sohal et al., 2009). Given the possibility of 
reprogramming neural cells from induced Pluripotent Stem Cells (iPSCs), future 
perspectives include the need to study Calcium channel physiology in PV+ 
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GABAergic cells reprogrammed from subjects with shared CACNA1I genetic 
variants. This approach will foster an in vivo characterization of the molecular 
bases of sleep spindle impairment that could in turn lead to novel therapeutic 
targets for SCZ.      
 
Despite the use of conventional classificatory systems such as the DSM to 
identifiy experimental populations, the theoretical framework in which my work 
is set can be bridged with the Research Domain Criteria (RDoC) proposed by 
the National Institute of Mental Health of the United States. Indeed, RDoC 
promote a shift in research design from diagnostic categories towards 
dimensions or systems, which are supported by neuroscience and can be the 
basis for objective measures of psychopathology (Insel and Cuthbert, 2015). 
Endophenotypes are uniquely informative in traditional diagnosis-based as well 
as emerging RDoC contexts, “offering a bridge between the two approaches to 
psychopathology classification and research” (Braff, 2015). 
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